Explore advanced leukemia treatment options at Liv Hospital. From targeted therapies and CAR-T to haploidentical stem cell transplants using CD34+ selection.
Send us all your questions or requests, and our expert team will assist you.
Treatment and Procedures
Receiving a leukemia diagnosis is the beginning of a challenging journey, but it is a journey you do not have to walk alone. The goal of leukemia treatment at Liv Hospital is clear: to achieve a complete remission and, whenever possible, a permanent cure.
We move beyond the “one-size-fits-all” approach. By utilizing the genetic data gathered during your evaluation, we construct a personalized battle plan. This may range from oral targeted therapies for chronic conditions to high-intensity stem cell transplants for acute cases. Our integrated campus houses both specialized hematology wards and the LivMedCell Regenerative Medicine Center, ensuring that international patients have access to the latest FDA-approved protocols and cutting-edge cellular engineering under one roof.
For many patients with Acute Myeloid Leukemia (AML) or high-risk Acute Lymphoblastic Leukemia (ALL), chemotherapy alone is not enough to prevent a relapse. A stem cell transplant (often called a Bone Marrow Transplant) replaces the diseased marrow with a healthy one.
This procedure involves using stem cells from a healthy donor. The new donor immune system takes over and attacks any remaining leukemia cells (the Graft-Versus-Leukemia effect).
What if you don’t have a fully matched donor? This is a common barrier for international patients. Liv Hospital specializes in Haploidentical (Half-Match) Transplants.
Before a transplant is considered, the first step is often to reduce the cancer burden using medication.
Chemotherapy uses powerful drugs to stop the growth of cancer cells.
Unlike chemo, which affects all fast-growing cells, targeted drugs attack specific abnormalities.
We engineer your own immune system to fight cancer.
Liv Hospital is one of the few centers in the region with an in-house Regenerative Medicine Stem Cell Manufacturing Center (LivMedCell) that meets international GMP (Good Manufacturing Practice) standards. This facility is critical for our success rates.
In allogeneic transplants, the risk of Graft Versus Host Disease (GVHD) is a major concern. Using the CliniMACS® system, we perform CD34+ selection.
If a patient develops severe Graft Versus Host Disease or has poor engraftment, we can manufacture and infuse Mesenchymal Stem Cells. These “helper” cells soothe inflammation and support the bone marrow microenvironment, aiding recovery.
Send us all your questions or requests, and our expert team will assist you.
While less common as a standalone treatment for leukemia, radiation is sometimes used:
Leukemia treatment is intense. To keep you safe, we provide comprehensive supportive care:
Yes. With aggressive treatment, particularly allogeneic stem cell transplantation, many patients with acute leukemia achieve long-term remission and are considered cured. For chronic leukemias, “functional cure” (where the disease is undetectable while on medication) is the goal.
The transplant process itself (the infusion of cells) takes only a few hours. However, the entire hospital stay is typically 4 to 6 weeks. This includes the conditioning chemotherapy before the transplant and the isolation period afterward while waiting for the new cells to grow (engraftment).
Common side effects include hair loss, nausea, fatigue, and increased risk of infection. Long-term effects can include fertility issues (which is why we discuss sperm/egg freezing before treatment) and thyroid changes. Our supportive care team manages these actively.
Currently, CAR-T therapy is FDA-approved for specific types of relapsed B-cell ALL (in children/young adults) and certain lymphomas. It is not yet a first-line treatment for AML or CLL, but clinical trials are expanding its use.
We offer the same FDA-approved protocols and technology (like CD34+ selection and Haploidentical transplants) found in top US centers, but with faster scheduling and a more personalized, service-oriented environment. Our ability to manufacture cells in-house via LivMedCell gives us a unique advantage in handling complex cases.
Your Comparison List (you must select at least 2 packages)
